ATI PHARMACOLOGY 2019 PROCTORED EXAM -
ii ii ii ii ii
STUDY GUIDE ii
Pharmacology iFinal iExam iQuestions
1. When iadministering ithe idrug isenna ito ia ipatient, ia ihealth icare iprovider imust iinform
itheipatient iof iwhich iof ithe ifollowing
a. This idrug iis iintended ito ilower iblood ipressure iand iis ibest iused iin
icombinationiwith iother iantihypertensives
b. This idrug iis inot iintended ifor ilong iterm iuse
c. The ipatient imust ilimit ihis/her ifiber iintake
d. Advise ipatient ito ichange ipositions islowly ito ilimit ithe irisk iof
iorthostaticihypotension
2. When igiving idigoxin i(Lanoxin) ito ia ipatient, ithe ihealth icare iprovider inotices ivarious
isigns iand isymptoms iof ian ioverdose. iThe ihealth icare iprovider iknows ito igive iwhich iof
itheifollowing ito ireverse idigoxin itoxicity
a. Naloxone
b. Vitamin
iKic. i Digibind
d. i Fluemanzil
3. While iproviding ian iAngiotensin-converting ienzyme i(ACE) iinhibitor, ithe ipatient iasks
iwhatithe iaction iof ithe idrug iis. iAs ia ihealth icare iprovider, iyou iexplain ithat ithe iaction iof ian
iACEiinhibitor iis
a. To ilower iblood ipressure iby iblocking ithe iconversion iof iangiotensin iI
itoivasoconstrictor iangiotensin iII
b. To iinhibit ireabsorption iof isodium iback iinto ithe ibody, iultimately iincreasing
iurineioutput iand ilowering iblood ipressure
c. To idecrease iheart irate iand iblood ipressure iby icompeting iwith iBeta1 iand
iBeta2ireceptors iin ithe iheart iand ilungs
d. To ilower iblood iglucose iby istimulating ithe irelease iof iinsulin
4. Which iof ithe ifollowing itypes iof iinsulin iis i“long-acting”?
a. Lispro i(Humalog)
b. NPH i(Humulin iN)
c. Regular iinsulin i(Humulin
iR)id. i Glargine i(Lantus)
1. What iis ithe itherapeutic iuse iof imetformin?
A. Lower iblood ipressure.
B. To idiminish iseizure iactivity.
C. The imaintenance iof ia iperson’s iblood iglucose.
D. Increase iheart irate iand idecrease igastrointestinal isecretions.
,ATI PHARMACOLOGY 2019 PROCTORED EXAM -
ii ii ii ii ii
STUDY GUIDE ii
1. What iis ithe icorrect idefinition ifor iabsorption iof ia idrug?
A. Movement iof idrug ifrom isite iof iadministration ito ivarious itissues iof ithe ibody.
B. Describes ithe iabsorption, idistribution, imetabolism i& iexcretion iof idrugs.
C. These itypes iof idrugs ican ibe itaken iover ithe icounter.
D. This iaddresses ihow ivarious idrugs iaffect idifferent iforms iof ithe ibody.
2. What ido iyou iassess ifor iin ia ipatient iwho iis ion iValproate? iSelect iall ithat
iapply.iA. i Suicidal ithoughts
B. i Monitor ifor
iseizures.iC. i Bipolar
idisorder.
D. iMigraines.
3. What iis itrue iabout ifood iand idrug iprecautions? iSelect iall ithat iapply.
A. You imust ilimit icertain itypes iof ifood ior iconcurrent iadministration iof icertain
itypesiof idrugs.
B. Certain icombinations iof ifood iand idrugs ican icause iadverse ireactions.
C. Precautions imay irequire ilimiting icertain itypes iof ifood ior iconcurring idrugs
iratherithan irestricting ithe idrug iitself.
D. When ione idrug ichanges ithe iway, ianother idrug iaffects ithat idrug.
1. ACE iInhibitors iare iused iin ithe itreatment iof iall iEXCEPT:
a. Hypertension
b. Heart
iFailureic.
i Hypotension
d. i Diabetic inephropathy
2. Which iof ithe ifollowing iis iused ito itreat imigraine
iheadaches?ia. i Beta-blockers
b. Cholinesterase iInhibitors
c. ACE iinhibitors
d. Anti-epileptic idrugs i(AEDs)
3. When iadministering ia iSerotonin iAntagonist iit iis iimportant ito imonitor ifor
a. Intake iand ioutput
b. Mental istatus ichanges
c. Respiratory irate
d. Anorexia
,ATI PHARMACOLOGY 2019 PROCTORED EXAM -
ii ii ii ii ii
STUDY GUIDE ii
4. Which iof ithe ifollowing iis ithe iantidote ifor
iHeparin?ia. i Protamine isulfate
, ATI PHARMACOLOGY 2019 PROCTORED EXAM -
ii ii ii ii ii
STUDY GUIDE ii
b. Vitamin iK
c. Naloxone
d. Toradol
1. A ipatient ihas ibeen itaking ihydrocodone, iand iopioid ianalgesic ifor itheir imoderate
ipain, iand ithey ihave itaken iover itheir iprescribed idose. iWhat ishould iyou igive ias ithe iantidote iif
ithey iexperience itoxicity?
A. Naloxone
B. N-acetylcysteine
C. Atropine
D. Digoxin iimmune iFab
1. A ipatient iis ibeing ieducated ion itaking ilevothyroxine, ia idrug iused ito ibalance
ithyroidiactivity. iWhat ishould iyou iinclude iin itheir ieducation?
A. iDon’t ibother iyour ihealth icare iprofessionals iif iyou iexperience iside ieffectsiB.
i Take ithis iat ithe isame itime ievery iday
C. Thyroid itests iare iunnecessary iwhile itaking ithis idrug
D. It iis iokay ito itake ithis idrug iif iyou ihave irecently ihad ia imyocardial iinfarction
1. A ipatient istates ihe iexperiences ianxiety iand ihas ipanic iattacks iat ileast ionce ia iweek.
iWhatimight ibe ihelpful ifor ithis ipatient?
A. Phenytoin i(Dilantin)
B. Lithium
C. Alprazolam i(Xanax)
D. Spironolactone
1. Which iof ithe ifollowing iis iNOT ian iopioid ior iNSAID?
A. Morphine
B. Ibuprofen
C. Hydromorphonei
D. i Acetaminophen
1) Why iis iit iimportant ito imonitor iins iand iouts iwith ipatients iusing iACE iinhibitors?
A. To iassess ifor irenal iimpairment
B. You imust imake isure ithe ipatient iis ireceiving iadequate ifluid iintake
C. To iassess ithe ipatient ifor ipotential iheart ifailure
D. You imust iassess ifor iNSAID iuse
E. To iassess ifor idecreased iblood ipressure
ii ii ii ii ii
STUDY GUIDE ii
Pharmacology iFinal iExam iQuestions
1. When iadministering ithe idrug isenna ito ia ipatient, ia ihealth icare iprovider imust iinform
itheipatient iof iwhich iof ithe ifollowing
a. This idrug iis iintended ito ilower iblood ipressure iand iis ibest iused iin
icombinationiwith iother iantihypertensives
b. This idrug iis inot iintended ifor ilong iterm iuse
c. The ipatient imust ilimit ihis/her ifiber iintake
d. Advise ipatient ito ichange ipositions islowly ito ilimit ithe irisk iof
iorthostaticihypotension
2. When igiving idigoxin i(Lanoxin) ito ia ipatient, ithe ihealth icare iprovider inotices ivarious
isigns iand isymptoms iof ian ioverdose. iThe ihealth icare iprovider iknows ito igive iwhich iof
itheifollowing ito ireverse idigoxin itoxicity
a. Naloxone
b. Vitamin
iKic. i Digibind
d. i Fluemanzil
3. While iproviding ian iAngiotensin-converting ienzyme i(ACE) iinhibitor, ithe ipatient iasks
iwhatithe iaction iof ithe idrug iis. iAs ia ihealth icare iprovider, iyou iexplain ithat ithe iaction iof ian
iACEiinhibitor iis
a. To ilower iblood ipressure iby iblocking ithe iconversion iof iangiotensin iI
itoivasoconstrictor iangiotensin iII
b. To iinhibit ireabsorption iof isodium iback iinto ithe ibody, iultimately iincreasing
iurineioutput iand ilowering iblood ipressure
c. To idecrease iheart irate iand iblood ipressure iby icompeting iwith iBeta1 iand
iBeta2ireceptors iin ithe iheart iand ilungs
d. To ilower iblood iglucose iby istimulating ithe irelease iof iinsulin
4. Which iof ithe ifollowing itypes iof iinsulin iis i“long-acting”?
a. Lispro i(Humalog)
b. NPH i(Humulin iN)
c. Regular iinsulin i(Humulin
iR)id. i Glargine i(Lantus)
1. What iis ithe itherapeutic iuse iof imetformin?
A. Lower iblood ipressure.
B. To idiminish iseizure iactivity.
C. The imaintenance iof ia iperson’s iblood iglucose.
D. Increase iheart irate iand idecrease igastrointestinal isecretions.
,ATI PHARMACOLOGY 2019 PROCTORED EXAM -
ii ii ii ii ii
STUDY GUIDE ii
1. What iis ithe icorrect idefinition ifor iabsorption iof ia idrug?
A. Movement iof idrug ifrom isite iof iadministration ito ivarious itissues iof ithe ibody.
B. Describes ithe iabsorption, idistribution, imetabolism i& iexcretion iof idrugs.
C. These itypes iof idrugs ican ibe itaken iover ithe icounter.
D. This iaddresses ihow ivarious idrugs iaffect idifferent iforms iof ithe ibody.
2. What ido iyou iassess ifor iin ia ipatient iwho iis ion iValproate? iSelect iall ithat
iapply.iA. i Suicidal ithoughts
B. i Monitor ifor
iseizures.iC. i Bipolar
idisorder.
D. iMigraines.
3. What iis itrue iabout ifood iand idrug iprecautions? iSelect iall ithat iapply.
A. You imust ilimit icertain itypes iof ifood ior iconcurrent iadministration iof icertain
itypesiof idrugs.
B. Certain icombinations iof ifood iand idrugs ican icause iadverse ireactions.
C. Precautions imay irequire ilimiting icertain itypes iof ifood ior iconcurring idrugs
iratherithan irestricting ithe idrug iitself.
D. When ione idrug ichanges ithe iway, ianother idrug iaffects ithat idrug.
1. ACE iInhibitors iare iused iin ithe itreatment iof iall iEXCEPT:
a. Hypertension
b. Heart
iFailureic.
i Hypotension
d. i Diabetic inephropathy
2. Which iof ithe ifollowing iis iused ito itreat imigraine
iheadaches?ia. i Beta-blockers
b. Cholinesterase iInhibitors
c. ACE iinhibitors
d. Anti-epileptic idrugs i(AEDs)
3. When iadministering ia iSerotonin iAntagonist iit iis iimportant ito imonitor ifor
a. Intake iand ioutput
b. Mental istatus ichanges
c. Respiratory irate
d. Anorexia
,ATI PHARMACOLOGY 2019 PROCTORED EXAM -
ii ii ii ii ii
STUDY GUIDE ii
4. Which iof ithe ifollowing iis ithe iantidote ifor
iHeparin?ia. i Protamine isulfate
, ATI PHARMACOLOGY 2019 PROCTORED EXAM -
ii ii ii ii ii
STUDY GUIDE ii
b. Vitamin iK
c. Naloxone
d. Toradol
1. A ipatient ihas ibeen itaking ihydrocodone, iand iopioid ianalgesic ifor itheir imoderate
ipain, iand ithey ihave itaken iover itheir iprescribed idose. iWhat ishould iyou igive ias ithe iantidote iif
ithey iexperience itoxicity?
A. Naloxone
B. N-acetylcysteine
C. Atropine
D. Digoxin iimmune iFab
1. A ipatient iis ibeing ieducated ion itaking ilevothyroxine, ia idrug iused ito ibalance
ithyroidiactivity. iWhat ishould iyou iinclude iin itheir ieducation?
A. iDon’t ibother iyour ihealth icare iprofessionals iif iyou iexperience iside ieffectsiB.
i Take ithis iat ithe isame itime ievery iday
C. Thyroid itests iare iunnecessary iwhile itaking ithis idrug
D. It iis iokay ito itake ithis idrug iif iyou ihave irecently ihad ia imyocardial iinfarction
1. A ipatient istates ihe iexperiences ianxiety iand ihas ipanic iattacks iat ileast ionce ia iweek.
iWhatimight ibe ihelpful ifor ithis ipatient?
A. Phenytoin i(Dilantin)
B. Lithium
C. Alprazolam i(Xanax)
D. Spironolactone
1. Which iof ithe ifollowing iis iNOT ian iopioid ior iNSAID?
A. Morphine
B. Ibuprofen
C. Hydromorphonei
D. i Acetaminophen
1) Why iis iit iimportant ito imonitor iins iand iouts iwith ipatients iusing iACE iinhibitors?
A. To iassess ifor irenal iimpairment
B. You imust imake isure ithe ipatient iis ireceiving iadequate ifluid iintake
C. To iassess ithe ipatient ifor ipotential iheart ifailure
D. You imust iassess ifor iNSAID iuse
E. To iassess ifor idecreased iblood ipressure
